0 26

Cited 2 times in

Cited 0 times in

Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetes

Authors
 Chen, Yuping  ;  Dong, Bingtian  ;  Jin, Xinrui  ;  Liu, Chuan  ;  Zheng, Ming-Hua  ;  Liang, Xiao  ;  Sun, Yameng  ;  Lee, Hye Won  ;  Lin, Huapeng  ;  Tsochatzis, Emmanuel  ;  Petta, Salvatore  ;  Bugianesi, Elisabetta  ;  Yoneda, Masato  ;  Hagstrom, Hannes  ;  Boursier, Jerome  ;  Calleja, Jose Luis  ;  Goh, George Boon-Bee  ;  Chan, Wah-Kheong  ;  Gallego-Duran, Rocio  ;  Sanyal, Arun J.  ;  De Ledinghen, Victor  ;  Newsome, Philip N.  ;  Fan, Jian-Gao  ;  Castera, Laurent  ;  Lai, Michelle  ;  Fournier-Poizat, Celine  ;  Wong, Grace Lai-Hung  ;  Pennisi, Grazia  ;  Armandi, Angelo  ;  Nakajima, Atsushi  ;  Liu, Wen-Yue  ;  Shang, Ying  ;  Saint-Loup, Marc De  ;  Llop, Elba  ;  Teh, Kevin Kim Jun  ;  Lara-Romero, Carmen  ;  Asgharpour, Amon  ;  Mahgoub, Sara  ;  Chan, Mandy Sau-Wai  ;  Lannes, Adrien  ;  Romero-Gomez, Manuel  ;  Hu, Airong  ;  Li, Yiling  ;  Zeng, Qing-Lei  ;  Gou, Wei  ;  Bian, Hua  ;  Han, Xiao  ;  Sun, Chenlin  ;  Kim, Seung Up  ;  Yip, Terry Cheuk-Fung  ;  Teng, Gao-Jun  ;  Wong, Vincent Wai-Sun  ;  Qi, Xiaolong 
Citation
 GUT, Vol.75(3) : 576-587, 2026-01 
Journal Title
GUT
ISSN
 0017-5749 
Issue Date
2026-01
Keywords
HEPATIC FIBROSIS ; DIABETES MELLITUS, TYPE 2 ; FATTY LIVER
Abstract
Background Current guidelines recommend a two-step approach for risk stratification of metabolic dysfunction-associated steatotic liver disease (MASLD), starting with Fibrosis-4 index (FIB-4) followed by liver stiffness measurement (LSM) using vibration-controlled transient elastography (VCTE). Objective To evaluate this approach for predicting advanced fibrosis and liver-related events (LREs) in patients with type 2 diabetes (T2D). Design A prospective liver biopsy cohort of T2D patients with histologically confirmed MASLD from seven centres in China was used to assess diagnostic performance for advanced fibrosis. The international VCTE-Prognosis cohort, including T2D patients with MASLD who underwent VCTE at 16 centres in the USA, Europe and Asia, with longitudinal follow-up, was used to assess LREs, defined as hepatic decompensation or hepatocellular carcinoma. Results 4781 participants were included. In the liver biopsy cohort (n=352; 22.2% with advanced fibrosis), applying LSM thresholds of <8 kPa and >12 kPa after FIB-4 classified patients into 63.4% low-risk, 9.4% intermediate-risk and 27.3% high-risk, with a correct classification rate of 71%. In the VCTE-Prognosis cohort (n=4429; median follow-up 51.3 (IQR 27.4-70.7) months), 140 (3.2%) patients developed LREs (110 (2.5%) with hepatic decompensation and 59 (1.3%) with hepatocellular carcinoma). The two-step approach classified 72.6%, 6.8% and 20.6% of patients into low-risk, intermediate-risk and high-risk groups, with corresponding 5-year cumulative LRE incidences of 0.7%, 0.9% and 11.8%. Refining classification of intermediate FIB-4 patients using LSM <10 kPa (low-risk) and >15 kPa (high-risk) reduced the intermediate-risk group to 5.6% while preserving predictive accuracy. Conclusion The non-invasive two-step approach of FIB-4 followed by LSM effectively stratifies MASLD-related advanced fibrosis and LREs risk in T2D. Applying LSM cut-offs of 10 and 15 kPa further optimises risk stratification for future LREs.
Full Text
https://gut.bmj.com/content/75/3/576
DOI
10.1136/gutjnl-2025-337506
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Seung Up(김승업) ORCID logo https://orcid.org/0000-0002-9658-8050
Lee, Hye Won(이혜원) ORCID logo https://orcid.org/0000-0002-3552-3560
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/211231
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links